Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension
Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition in which an organic thrombus remains in the pulmonary artery (PA) even after receiving anticoagulation therapy for more than 3 months and is complicated by pulmonary hypertension (PH), leading to right-sided heart failure and death...
Main Authors: | Naoyuki Otani, Ryo Watanabe, Takashi Tomoe, Shigeru Toyoda, Takanori Yasu, Takaaki Nakamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/4/3979 |
Similar Items
-
Chronic Thromboembolic Pulmonary Hypertension in Females: Clinical Features and Survival
by: Yan Wu, et al.
Published: (2022-09-01) -
Epidemiology and Management of Chronic Thromboembolic Pulmonary Hypertension in Greece. Real-World Data from the Hellenic Pulmonary Hypertension Registry (HOPE)
by: Eftychia Demerouti, et al.
Published: (2021-09-01) -
Emergent balloon pulmonary angioplasty in a patient with central‐type chronic thromboembolic pulmonary hypertension with cardiac shock
by: Hiroto Tamura, et al.
Published: (2022-12-01) -
Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy
by: Nicolas M. Maneiro Melon, et al.
Published: (2023-01-01) -
Safety and efficacy of balloon pulmonary angioplasty for technically operable chronic thromboembolic pulmonary hypertension
by: Jinzhi Wang, et al.
Published: (2024-01-01)